Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
36
IPHA Quote, Financials, Valuation and Earnings
Last price:
$1.88
Seasonality move
:
-11.27%
Day range:
$1.81 - $1.94
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.21x
P/B ratio:
17.10x
Volume:
57.9K
Avg. volume:
24K
1-year change:
-24.4%
Market cap:
$157.1M
Revenue:
$13.7M
EPS (TTM):
-$0.45
Earnings Data
Next earnings date for IPHA
May 13
2025
Most recent earnings per share
--
Missed by --
(Apr 14/2025)
Consensus Estimate
--
(Apr 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPHA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2020 | Q4 | -- | -- | -- | -$0.17 | -- |
| 11/13/2019 | Q3 | -- | -- | -- | $0.05 | -- |
Innate Pharma SA Earnings Questions
-
How Much did Innate Pharma SA Generate in Revenue Last Quarter?
Innate Pharma SA reported -- worth of top line sales in its most recent quarter.
-
Did Innate Pharma SA Beat Earnings Last Quarter?
Innate Pharma SA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Innate Pharma SA Profitable?
Innate Pharma SA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Innate Pharma SA EPS Next Year?
Innate Pharma SA's earnings are forecast to decrease from -$0.66 per share to -- per share next year representing a decrease of -55.87%.
-
When is Innate Pharma SA's Earnings Date?
Innate Pharma SA's next earnings date is May 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
